CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The POINT project seeks to develop biomarkers and clinical guidelines to manage non-communicable diseases arising from the post-acute phase of COVID-19. It aims to provide tools for healthcare systems to address the long-term health impacts of COVID-19 on patients.
The post-acute phase (PAP) of COVID-19, occurring ≥4 months after the acute phase, is associated with an increased risk for the development of non-communicable diseases (NCDs).
The risk of complications in this phase does not depend on the severity of the acute phase.
In the EU, more than 183 million cases of COVID-19 have been reported and up to 70% of patients suffer reduced organ function in the PAP.
Our conservative estimate it that 5% of people who have suffered COVID-19 are at risk of deve…
KOBENHAVNS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Hillerod
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Estonia, Tartu
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Leuven
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
